Who owns CYTOKINETICS INC?
- CUSIP Number: 23282wac4
Tip: Access positions for across all investors
Analyze quarterly positions in Cytokinetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytokinetics stock
Who bought or sold CYTOKINETICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Balyasny Asset Management | 36M | $52M | 0% | Mar 2026 |
|
| FMR | 24M | $34M | -23% | Dec 2025 |
|
| Nuveen | 14M | $21M | 180% | Mar 2026 |
|
| Two Sigma Investments | 14M | $20M | 62% | Mar 2026 |
|
| Lazard Asset Management | 11M | $167k | -3% | Mar 2026 |
|
| Leucadia National Corporation | 5.4M | $7.9M | 27% | Mar 2026 |
|
| Bank of America Corporation | 5.2M | $7.5M | 100% | Mar 2026 |
|
| Wellington Management Company | 5.1M | $7.3M | -66% | Dec 2025 |
|
| Capstone Investment Advisors | 5.0M | $7.3M | 0% | Mar 2026 |
|
| Morgan Stanley | 3.2M | $4.6M | 100% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 3.2M | $4.5M | 110% | Dec 2025 |
|
| Goldman Sachs Group | 1.8M | $2.6M | -54% | Mar 2026 |
|
| Context Capital Management | 1.4M | $2.0M | 0% | Mar 2026 |
|
| Advent Capital Management | 1.1M | $1.7M | -35% | Mar 2026 |
|
| Jane Street | 425k | $626k | 0% | Mar 2026 |
|
| SSI Investment Management | 308k | $450k | 0% | Mar 2026 |
|
| Bank of New York Mellon | 200k | $292k | 0% | Mar 2026 |
|
| GAMCO Asset Management | 200k | $284k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 170k | $248k | 100% | Mar 2026 |
|
| Russell Investments | 140k | $205k | 0% | Mar 2026 |
|
| Barclays | 94k | $134k | -64% | Dec 2025 |
|
| SG Americas Securities | 2.1k | $308k | -65% | Mar 2026 |
|
Who sold out of Cytokinetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Groupama Asset Managment | Dec 2025 | 1.2M | $1.6M |
| Gabelli Funds | Sep 2025 | 1.0M | $1.3M |
| Jpmorgan Chase & Co | Sep 2025 | 989k | $1.3M |
| Shenkman Capital Management | Dec 2025 | 339k | $489M |